NCT00057460View on ClinicalTrials.gov

Effect of Talampanel (an AMPA Receptor Blocker) on Brain Activity

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

May 31, 2006

Conditions
Healthy
Interventions
DRUG

Talampanel

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00057460 - Effect of Talampanel (an AMPA Receptor Blocker) on Brain Activity | Biotech Hunter | Biotech Hunter